22-(4′-py)-JA

Modify Date: 2024-01-03 11:47:46

22-(4′-py)-JA Structure
22-(4′-py)-JA structure
Common Name 22-(4′-py)-JA
CAS Number 1178895-15-2 Molecular Weight 598.60
Density N/A Boiling Point N/A
Molecular Formula C32H30N4O8 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of 22-(4′-py)-JA


22-(4′-py)-JA is a semisynthetic derivative of junamycin A (JA) that can be isolated from the Thai blue sponge (Xestospongia sp.). 22-(4′-py)-JA has antimetastatic activity and can inhibit AKT/mTOR/p70S6K signaling. 22-(4′-py)-JA inhibits tumor cell invasion and tube formation in human umbilical vein endothelial cells (HUVEC), downregulates metalloproteinases (MMP-2 and MMP-9), hypoxia-inducible factor 1α (HIF-1α) and vascular endothelial growth factor (VEGF). 22-(4′-py)-JA has potent anticancer activity against non-small cell lung cancer (NSCLC)[1].

 Names

Name 22-(4′-py)-JA

 22-(4′-py)-JA Biological Activity

Description 22-(4′-py)-JA is a semisynthetic derivative of junamycin A (JA) that can be isolated from the Thai blue sponge (Xestospongia sp.). 22-(4′-py)-JA has antimetastatic activity and can inhibit AKT/mTOR/p70S6K signaling. 22-(4′-py)-JA inhibits tumor cell invasion and tube formation in human umbilical vein endothelial cells (HUVEC), downregulates metalloproteinases (MMP-2 and MMP-9), hypoxia-inducible factor 1α (HIF-1α) and vascular endothelial growth factor (VEGF). 22-(4′-py)-JA has potent anticancer activity against non-small cell lung cancer (NSCLC)[1].
Related Catalog
In Vivo 22-(4′-py)-JA
References

[1]. Iksen I, et al. Preclinical Characterization of 22-(4'-Pyridinecarbonyl) Jorunnamycin A against Lung Cancer Cell Invasion and Angiogenesis via AKT/mTOR Signaling. ACS Pharmacol Transl Sci. 2023 Jul 25;6(8):1143-1154.

 Chemical & Physical Properties

Molecular Formula C32H30N4O8
Molecular Weight 598.60